Treatment & Management
The research led by this Think Tank aims to optimize treatment strategies for people living and aging with HIV and STBBIs to promote long-term engagement in care, reduce comorbidities, and improve quality of life.
-
CTN 337: The FAST-TRACK Study
An open-label individual-level randomized controlled trial to compare point of care HCV RNA testing and nurse-led rapid treatment initiation to standard of care to enhance treatment uptake in persons with hepatitis C in a transient correctional setting
-
CTNPT 054: Falls in older persons with HIV
Falls in older persons with HIV: Frequency, risk factors and feasibility of a future interventional trial
-
CTNPT 052: Glycoprotein 120 as a pan-toxin
Exploring the role of the soluble glycoprotein 120 as a pan-toxin driving immune dysfunction and accelerated aging in people living with HIV
-
CTN 338: PLATINUM-CAN
Placebo-controlled randomized trial of tecovirimat in non-hospitalized patients with Mpox: Canadian Feasibility Study
-
-
CTNPT 050: Perception of menopausal hormone therapy among women living with HIV
Perception of menopausal hormone therapy amongst women living with HIV: A feasibility study for a future randomized controlled trial
-
-
-
CTNPT 043: Endocannabinoid system and inflamm-aging in HIV-associated atherosclerosis
Interplay between expanded endocannabinoid (eCB) system and inflamm-aging: Implication for accelerated atherosclerosis in people living with HIV (PLWH) under ART
-
CTN 326: LIVEHIV Cohort Plus
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV